Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: A systematic review
详细信息 查看全文
- 作者：Wenxiao Jianga ; jiangwenxiao@163.com" class="auth_mail ; Qi Shena ; wzlunwen@163.com" class="auth_mail ; Miaomiao Chena ; mmcwzmc@163.com" class="auth_mail ; Ying Wanga ; wy815161578@163.com" class="auth_mail ; Qingfeng Zhoua ; mickeyzqf@126.com" class="auth_mail ; Xuejie Zhub ; zxj1022@163.com" class="auth_mail ; Xueqiong Zhua ; zjwzzxq@163.com" class="auth_mail
- 关键词：Levonorgestrel-releasing intrauterine systems ; Uterine leiomyoma ; Uterine volume ; Leiomyoma volume ; Endometrial thickness
- 刊名：Steroids
- 出版年：August 2014
- 年：2014
- 卷：86
- 期：Complete
- 页码：69-78
- 全文大小：530 K
文摘
- •
The efficacy and safety of LNG-IUSs use in women with symptomatic uterine leiomyoma.
- •
LNG-IUSs could decrease uterine volume and endometrial thickness.
- •
LNG-IUSs could reduce menstrual blood loss.
- •
LNG-IUS expulsion was related to leiomyoma size.
- •
LNG-IUSs have no adverse effects on the ovarian function except for ovarian cysts.